An Observational Study of Avastin (Bevacizumab) in Patients With HER2-metastatic or Locally Advanced Breast Cancer

CompletedOBSERVATIONAL
Enrollment

228

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Breast Cancer
Trial Locations (82)

10003

Troyes

11108

Narbonne

13004

Marseille

13273

Marseille

13285

Marseille

13616

Aix-en-Provence

13617

Aix-en-Provence

14076

Caen

16470

Saint-Michel-sur-Orge

16800

Soyaux

20176

Ajaccio

20200

Bastia

21079

Dijon

22015

Saint-Brieuc

24000

Périgueux

25030

Besançon

26102

Romans-sur-Isère

26953

Valence

27025

Évreux

28630

Le Coudray

29609

Brest

31076

Toulouse

31240

Saint-Jean

33030

Bordeaux

33077

Bordeaux

33310

Lormont

34535

Béziers

35768

Saint-Grégoire

36019

Châteauroux

38000

Grenoble

38700

La Tronche

40107

Dax

41260

La Chaussée-Saint-Victor

42271

Saint-Priest-en-Jarez

50102

Cherbourg Octeville

51057

Reims

54100

Nancy

55107

Verdun

56001

Vannes

56322

Lorient

57045

Metz

59003

Lille

59020

Lille

60021

Beauvais

60309

Senlis

62012

Arras

63011

Clermont-Ferrand

63050

Clermont-Ferrand

64100

Bayonne

67010

Strasbourg

69337

Lyon

69373

Lyon

73011

Chambéry

75181

Paris

75230

Paris

75231

Paris

75475

Paris

75571

Paris

75651

Paris

75674

Paris

75970

Paris

76000

Rouen

76044

Rouen

76290

Montivilliers

78105

Saint-Germain-en-Laye

80090

Amiens

83056

Toulon

85925

La Roche-sur-Yon

87042

Limoges

91161

Longjumeau

92100

Boulogne-Billancourt

92166

Antony

92210

Saint-Cloud

93009

Bobigny

94010

Créteil

94805

Villejuif

95520

Osny

95602

Eaubonne

01012

Bourg-en-Bresse

06250

Mougins

06189

Nice

Unknown

Toulouse

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01461044 - An Observational Study of Avastin (Bevacizumab) in Patients With HER2-metastatic or Locally Advanced Breast Cancer | Biotech Hunter | Biotech Hunter